| Schedule of Basic and Diluted Earnings Per Share |
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in thousands, except per share data) | | Three Months Ended June 30, | | Six Months Ended June 30, | | | | 2024 | | 2023 | | 2024 | | 2023 | | Numerator | | | | | | | | | | Net increase (decrease) in net assets resulting from operations | | $ | 41,852 | | | $ | 94,775 | | | $ | 132,816 | | | $ | 189,339 | | | Less: Total distributions declared | | (77,894) | | | (67,379) | | | (153,925) | | | (132,153) | | | Total Earnings (loss), net of total distributions | | (36,042) | | | 27,396 | | | (21,109) | | | 57,186 | | | | | | | | | | | | Earnings (loss), net of distributions attributable to common shares | | (36,042) | | | 27,108 | | | (21,110) | | | 56,552 | | | Add: Distributions declared attributable to common shares | | 77,157 | | | 66,672 | | | 152,387 | | | 130,696 | | | Numerator for basic and diluted change in net assets per common share | | $ | 41,115 | | | $ | 93,780 | | | $ | 131,277 | | | $ | 187,248 | | | | | | | | | | | | Denominator | | | | | | | | | | Basic weighted average common shares outstanding | | 160,748 | | 141,390 | | 159,096 | | 138,338 | | Common shares issuable | | 561 | | 694 | | 518 | | 1,249 | | Weighted average common shares outstanding assuming dilution | | 161,309 | | 142,084 | | 159,614 | | 139,587 | | | | | | | | | | | Change in net assets per common share: | | | | | | | | | | Basic | | $ | 0.26 | | | $ | 0.66 | | | $ | 0.83 | | | $ | 1.35 | | | Diluted | | $ | 0.25 | | | $ | 0.66 | | | $ | 0.82 | | | $ | 1.34 | |
|
| Schedule of Number of Anti-diluted Shares as Calculated Based on Weighted Average Closing Price of Common Stock |
The calculation of change in net assets resulting from operations per common share assuming dilution, excludes all anti-dilutive shares. For the three and six months ended June 30, 2024, and 2023, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | Anti-dilutive Securities | | 2024 | | 2023 | | 2024 | | 2023 | | Unvested common stock options | | 798 | | 3,146 | | 1,401 | | 2,499 | | Restricted stock units | | — | | 9,555 | | — | | 8,714 | | Unvested restricted stock awards | | 147 | | 65,346 | | 521 | | 59,854 | | | | | | | | | |
|